Ependymoma

An ependymoma is a type of tumor that arises from ependymal cells, which line the ventricles of the brain and the central canal of the spinal cord. These cells play a vital role in producing and circulating cerebrospinal fluid (CSF), the clear liquid that cushions the brain and spinal cord and removes metabolic waste. When ependymal cells grow uncontrollably, they form a mass that can exert pressure on surrounding neural structures, leading to a variety of neurological symptoms. Ependymomas account for approximately 2–3% of all primary brain tumors and about 6–12% of pediatric central nervous system tumors. They most commonly affect children and young adults but can occur at any age.

Ependymoma is a type of tumor that arises from ependymal cells lining the fluid-filled ventricles of the brain and the central canal of the spinal cord. These cells help produce and circulate cerebrospinal fluid (CSF), which cushions and nourishes the brain and spinal cord. Ependymomas can occur at any age but are most common in young children and adults in their 30s and 40s. They range from slow-growing (grade II) to more aggressive (anaplastic, grade III) forms. Symptoms depend on tumor size and location, often including headaches, nausea, balance problems, and limb weakness. Diagnosis typically involves MRI imaging and biopsy to confirm cell type and grade.

Ependymomas are typically slow-growing but can vary in aggressiveness. They may remain confined to the brain or spinal cord or, in rare cases, spread along CSF pathways. Effective management depends on accurate diagnosis, tumor location, and careful planning to minimize injury to healthy brain or spinal cord tissue.

---

Types of Ependymoma

Ependymomas are classified by their location, microscopic appearance, and molecular characteristics. Understanding these types helps guide treatment and predict clinical behavior.

1. Intracranial Ependymoma (Posterior Fossa)
   Located in the lower part of the skull near the cerebellum, these are the most common ependymomas in children. They often present with headaches, nausea, and balance problems due to blockage of CSF flow.

2. Supratentorial Ependymoma
   Found in the upper parts of the brain, above the tentorium cerebelli. These may cause seizures, personality changes, or focal neurological deficits depending on the lobe involved.

3. Spinal Ependymoma
   Arising within the spinal cord, these tumors can lead to back pain, weakness, or sensory changes in the arms or legs. They are more frequent in adults than in children.

4. Myxopapillary Ependymoma
   A subtype usually occurring in the filum terminale (lower end) of the spinal cord. They tend to grow slowly and can present with lower back pain or sciatica-like symptoms.

5. Subependymoma
   Generally benign and slow-growing lesions often found incidentally. They may cause symptoms only when they become large enough to obstruct CSF flow.

6. Anaplastic Ependymoma (WHO Grade III)
   A high-grade, more aggressive form that shows increased mitotic activity and cellular atypia under the microscope. These require more intensive therapy and carry a higher risk of recurrence.

7. Clear Cell Ependymoma
   Characterized by clear-appearing cells on histology, often seen in the cerebral hemispheres. They may behave more aggressively than classic ependymomas.

8. RELA Fusion–Positive Ependymoma
   Identified by a specific genetic alteration involving the RELA gene. This molecular feature is associated with a more aggressive course and is most common in supratentorial tumors in children.

---

Causes of Ependymoma

While the exact cause of ependymoma is not fully understood, research has identified several factors that may contribute to its development. Each of the following is a potential risk or contributing factor:

1. Genetic Mutations
   Changes in genes that regulate cell growth—such as RELA fusions—can trigger abnormal proliferation of ependymal cells.

2. Chromosomal Abnormalities
   Deletions or amplifications of chromosomes, including chromosome 22 loss, have been noted in many ependymoma cases.

3. Ionizing Radiation Exposure
   Previous radiation therapy to the head, especially during childhood, increases risk.

4. Inherited Cancer Syndromes
   Conditions such as Neurofibromatosis type 2 (NF2) can predispose individuals to ependymal tumors.

5. Chemical Carcinogens
   Occupational exposure to certain solvents or chemicals may play a role, though evidence is limited.

6. Viral Infections
   Some studies suggest a possible link between polyomavirus infection and ependymoma development.

7. Chromothripsis
   A phenomenon of massive chromosomal rearrangement occurring in a single event, leading to tumorigenesis.

8. Epigenetic Alterations
   Changes in DNA methylation patterns in ependymal cells can activate oncogenes or silence tumor suppressors.

9. Stem Cell Dysregulation
   Abnormal proliferation or failure of differentiation in neural stem cells lining the ventricles.

10. Inflammatory Microenvironment
    Chronic inflammation in the central nervous system may create a pro-tumorigenic environment.

11. Hormonal Factors
    Some hypotheses suggest that hormonal fluctuations in childhood and adolescence may influence tumor development.

12. Hypoxia
    Low oxygen levels in periventricular regions could induce genetic instability in ependymal cells.

13. Reactive Oxygen Species (ROS)
    Oxidative stress can damage DNA and promote malignant transformation.

14. Growth Factor Dysregulation
    Overexpression of platelet-derived growth factor (PDGF) or its receptor has been found in some tumors.

15. Cell Cycle Gene Overexpression
    Dysregulation of cyclins and cyclin-dependent kinases can accelerate cell division.

16. Tumor Microenvironment
    Abnormal interactions between tumor cells and surrounding glial or vascular cells can support growth.

17. Previous CNS Infection or Trauma
    Rarely, past infections or injuries to brain/spinal cord tissue may predispose to tumor formation.

18. Age-Related Genetic Instability
    Accumulation of DNA damage over time may explain the adult incidence of spinal ependymomas.

19. Radiation from Diagnostic Imaging
    Concerns exist about cumulative low-dose radiation, although risk remains small.

20. Unknown Sporadic Factors
    In most cases, ependymomas arise without any identifiable risk factor, reflecting the complex biology of these tumors.

---

 Symptoms of Ependymoma

Symptoms vary greatly depending on the tumor’s location and size. Below are twenty possible symptoms, each explained in simple terms:

1. Headache
   Persistent or worsening headache, especially in the morning, due to increased pressure in the skull.

2. Nausea and Vomiting
   Resulting from raised intracranial pressure as CSF flow becomes obstructed.

3. Balance Problems
   Difficulty walking or coordinating movements when the tumor presses on the cerebellum.

4. Seizures
   Abnormal electrical activity in the brain caused by irritation of the cortex in supratentorial tumors.

5. Vision Changes
   Blurred or double vision if pressure affects the cranial nerves controlling eye movement.

6. Hearing Loss or Tinnitus
   Rare, but may occur if a tumor near auditory pathways grows large.

7. Weakness in Arms or Legs
   Compression of motor pathways in spinal or intracranial regions.

8. Sensory Changes
   Numbness, tingling, or “pins and needles” sensations when sensory tracts are involved.

9. Back Pain
   Localized pain in the spine indicates a spinal ependymoma’s presence.

10. Radicular Pain
    Shooting pain along a nerve’s distribution, similar to sciatica, for lower spinal tumors.

11. Difficulty Urinating or Bowel Dysfunction
    Tumors in the lower spinal cord can disrupt autonomic control of bladder and bowel.

12. Personality or Behavioral Changes
    Frontal lobe involvement may cause mood swings, irritability, or cognitive slowing.

13. Speech Difficulties
    Tumors near language centers can impair speech production or comprehension.

14. Head Tilt or Torticollis
    Unusual head posture as a child compensates for balance disturbances.

15. Hydrocephalus Signs
    Enlarged head circumference in infants or bulging fontanelles due to CSF buildup.

16. Fatigue
    Generalized tiredness from the body’s effort to cope with increased pressure or tumor metabolism.

17. Neck Pain
    Upper spinal tumors can cause localized neck discomfort.

18. Ataxia
    Uncoordinated movements and swaying while standing or walking.

19. Dizziness
    A spinning sensation due to involvement of vestibular pathways.

20. Cognitive Impairment
    Problems with memory, attention, or concentration when cerebral cortex areas are affected.

---

Diagnostic Tests

Accurate diagnosis of ependymoma relies on a combination of clinical evaluation and a variety of diagnostic tests. Below, forty tests are grouped by type, each described in simple language.

Physical Exam

1. Neurological Examination
   Assessment of strength, sensation, reflexes, coordination, and cranial nerves to detect signs of central nervous system dysfunction.

2. Head Circumference Measurement (Infants)
   Monitoring growth of an infant’s skull to detect hydrocephalus from obstructed CSF flow.

3. Gait Analysis
   Observation of walking pattern to identify ataxia or imbalance.

4. Coordination Tests
   Finger-to-nose and heel-to-shin testing to assess cerebellar function.

5. Cranial Nerve Testing
   Checking eye movements, facial strength, hearing, and swallowing to identify focal lesions.

6. Reflex Testing
   Evaluating deep tendon reflexes for asymmetries indicating spinal cord involvement.

7. Sensory Mapping
   Determining areas of altered touch, pain, or temperature sensation.

8. Postural Stability Assessment
   Evaluating ability to maintain balance during standing.

Manual Tests

9. Flexion–Extension Maneuvers
   Assessing neck or back pain by gently moving the spine to locate tender areas.

10. Foramen Magnum Compression Test
    Gentle pressure at the skull base may reproduce symptoms in posterior fossa tumors.

11. Spurling’s Test
    Neck extension and rotation to assess nerve root compression in cervical lesions.

12. Straight Leg Raise Test
    Raising the leg to pinpoint nerve irritation in lower spinal tumors.

13. Valsalva Maneuver
    Asking the patient to bear down; increased pain can indicate spinal cord involvement.

14. Lhermitte’s Sign
    Neck flexion causing electric-shock sensations in limbs suggests spinal cord lesions.

15. Romberg Test
    Standing with feet together and eyes closed to highlight sensory or cerebellar deficits.

16. Palpation for Tenderness
    Feeling along the spine or skull base to locate areas of discomfort.

Laboratory and Pathological Tests

17. Complete Blood Count (CBC)
    Basic blood test to rule out anemia or infection that might mimic neurological symptoms.

18. Serum Electrolytes
    Checking sodium, calcium, and other electrolytes that influence nervous system function.

19. Tumor Marker Analysis
    Rarely, assays for proteins or markers that may be elevated in some ependymoma subtypes.

20. CSF Cytology
    Sampling cerebrospinal fluid to detect tumor cells floating in CSF pathways.

21. CSF Biochemical Studies
    Measuring protein and glucose levels in CSF, which may be altered by tumor presence.

22. Cytogenetic Testing
    Chromosome analysis from tumor biopsy to identify deletions or rearrangements.

23. Molecular Profiling
    Testing for RELA fusion or other gene alterations to guide prognosis.

24. Immunohistochemistry
    Staining tumor samples for proteins such as GFAP (glial fibrillary acidic protein) to confirm ependymal origin.

Electrodiagnostic Tests

25. Electroencephalogram (EEG)
    Recording brain electrical activity, useful when seizures are a presenting symptom.

26. Somatosensory Evoked Potentials (SSEPs)
    Measuring nerve pathway conduction speed; delays suggest spinal cord or brainstem involvement.

27. Motor Evoked Potentials (MEPs)
    Stimulating the brain and recording muscle responses; helps assess motor pathway integrity.

28. Brainstem Auditory Evoked Responses (BAERs)
    Testing hearing pathways through electrical responses, helpful for tumors near auditory tracts.

29. Electromyography (EMG)
    Evaluating electrical activity in muscles to detect nerve root or peripheral nerve involvement.

30. Nerve Conduction Studies (NCS)
    Measuring speed and strength of electrical signals in nerves, especially when limb symptoms occur.

Imaging Tests

31. Magnetic Resonance Imaging (MRI) – Brain
    The gold standard for detecting intracranial ependymomas, showing tumor size, location, and relation to CSF spaces.

32. MRI – Spine
    Identifies spinal cord tumors and assesses spread along CSF pathways.

33. Contrast-Enhanced MRI
    Uses gadolinium contrast to highlight tumor margins and vascularity.

34. Computed Tomography (CT) Scan
    Faster and widely available; useful in emergencies to detect calcifications or hemorrhage.

35. CT Myelography
    Injecting contrast into CSF spaces before CT to outline spinal cord lesions.

36. Positron Emission Tomography (PET) Scan
    Metabolic imaging to differentiate tumor tissue from post-treatment changes.

37. Functional MRI (fMRI)
    Maps brain activity areas to guide safe surgical planning away from critical cortex.

38. Diffusion Tensor Imaging (DTI)
    Visualizes white matter tracts to avoid key pathways during surgery.

39. Magnetic Resonance Spectroscopy (MRS)
    Analyzes chemical composition of lesions, distinguishing tumor from inflammation.

40. Ultrasound (Intraoperative)
    Used during surgery to locate tumor boundaries in real time, especially in infants through the open fontanelle.

Non-Pharmacological Treatments

Below are evidence-based approaches—organized into physiotherapy & electrotherapy, exercise therapies, mind-body techniques, and educational self-management—to support patients with ependymoma before, during, and after medical or surgical treatment.

A. Physiotherapy & Electrotherapy Therapies

1. Vestibular Rehabilitation
   Description: Specialized balance exercises to retrain the inner ear and brain pathways.
   Purpose: Reduce dizziness and improve coordination.
   Mechanism: Repetitive head and eye movements stimulate compensation in balance centers.

2. Neuromuscular Electrical Stimulation (NMES)
   Description: Mild electrical currents applied to weakened muscles.
   Purpose: Enhance muscle strength and prevent atrophy.
   Mechanism: Electrical pulses trigger muscle contractions, increasing fiber recruitment.

3. Transcutaneous Electrical Nerve Stimulation (TENS)
   Description: Low-voltage electrical stimulation for pain relief.
   Purpose: Alleviate neuropathic pain from nerve irritation.
   Mechanism: Electrical impulses block pain signals at the spinal gate.

4. Therapeutic Ultrasound
   Description: High-frequency sound waves applied via a probe.
   Purpose: Reduce inflammation and promote tissue healing.
   Mechanism: Micromechanical vibrations increase blood flow and cellular activity.

5. Cryotherapy
   Description: Application of cold packs to affected areas.
   Purpose: Control post-treatment swelling and pain.
   Mechanism: Vasoconstriction limits inflammatory mediators.

6. Heat Therapy (Thermotherapy)
   Description: Warm packs or infrared lamps for muscle relaxation.
   Purpose: Ease muscle stiffness and spasms.
   Mechanism: Vasodilation increases nutrient delivery and waste removal.

7. Manual Lymphatic Drainage
   Description: Gentle massage to stimulate lymph flow.
   Purpose: Prevent fluid buildup around the spinal canal.
   Mechanism: Moves lymphatic fluid toward drainage nodes.

8. Proprioceptive Neuromuscular Facilitation (PNF)
   Description: Stretch-hold-stretch patterns to improve flexibility.
   Purpose: Restore joint range of motion.
   Mechanism: Neurological reflexes promote muscle relaxation.

9. Gait Training with Parallel Bars
   Description: Supported walking practice.
   Purpose: Rebuild safe ambulation post-surgery or during weakness.
   Mechanism: Progressive weight-bearing stimulates motor learning.

10. Hydrotherapy (Aquatic Therapy)
    Description: Exercises performed in a warm pool.
    Purpose: Reduce joint stress and improve mobility.
    Mechanism: Buoyancy decreases gravitational load while resistance builds strength.

11. Balance Board Exercises
    Description: Standing and shifting weight on an unstable surface.
    Purpose: Enhance core and ankle stability.
    Mechanism: Constant micro-corrections train proprioceptive pathways.

12. Spinal Mobilization Techniques
    Description: Gentle manual movements of spinal segments.
    Purpose: Relieve stiffness and improve spinal alignment.
    Mechanism: Low-grade distraction and gliding stimulate joint receptors.

13. Soft Tissue Massage
    Description: Targeted massage of muscles and fascia.
    Purpose: Decrease muscle tension and pain.
    Mechanism: Mechanical pressure increases circulation and breaks adhesions.

14. Post-urethral Biofeedback
    Description: Real-time monitoring of pelvic floor muscle activity.
    Purpose: Strengthen bladder control.
    Mechanism: Visual or auditory prompts guide muscle contraction.

15. Functional Electrical Stimulation (FES) Cycling
    Description: Electric stimulation to leg muscles while pedaling a stationary cycle.
    Purpose: Improve cardiovascular fitness and muscle endurance.
    Mechanism: Coordinated stimulation and cycling induce aerobic conditioning.

B. Exercise Therapies

16. Gentle Yoga
    Description: Slow, mindful postures and breathing.
    Purpose: Enhance flexibility and reduce stress.
    Mechanism: Combines stretching with parasympathetic activation.

17. Tai Chi
    Description: Flowing martial arts-based movements.
    Purpose: Improve balance, coordination, and mental focus.
    Mechanism: Slow weight shifts reinforce proprioception and relaxation.

18. Pilates
    Description: Core-strengthening mat exercises.
    Purpose: Stabilize spine and improve posture.
    Mechanism: Emphasizes controlled, precise movements to recruit deep stabilizers.

19. Stationary Cycling
    Description: Low-impact aerobic workout.
    Purpose: Maintain cardiovascular health during treatment.
    Mechanism: Rhythmic leg movements improve circulation and endurance.

20. Resistance Band Strengthening
    Description: Elastic bands for light resistance exercises.
    Purpose: Rebuild muscle after weakness.
    Mechanism: Variable tension throughout motion strengthens fibers safely.

C. Mind-Body Techniques

21. Guided Imagery
    Description: Therapist-led visualization exercises.
    Purpose: Reduce anxiety and perceived pain.
    Mechanism: Activates relaxation response via focused attention.

22. Mindfulness Meditation
    Description: Nonjudgmental awareness of present sensations.
    Purpose: Improve emotional well-being and coping.
    Mechanism: Changes neural pathways to down-regulate stress circuits.

23. Progressive Muscle Relaxation
    Description: Systematic tensing and releasing of muscle groups.
    Purpose: Relieve physical tension and anxiety.
    Mechanism: Enhances interoceptive awareness and parasympathetic drive.

24. Biofeedback Training
    Description: Electronic monitoring of bodily functions (e.g., heart rate).
    Purpose: Teach self-regulation of stress and pain.
    Mechanism: Real-time feedback enables conscious control over autonomic responses.

25. Art Therapy
    Description: Creative expression through drawing or painting.
    Purpose: Facilitate emotional processing and stress relief.
    Mechanism: Engages reward pathways and externalizes difficult emotions.

D. Educational Self-Management

26. Symptom Diary Keeping
    Description: Daily log of pain, mood, and activities.
    Purpose: Identify triggers and track progress.
    Mechanism: Empowers patients to recognize patterns and adjust strategies.

27. Pain-Coping Skills Workshops
    Description: Group sessions teaching cognitive-behavioral strategies.
    Purpose: Reduce pain catastrophizing and improve function.
    Mechanism: Reframes negative thoughts and builds adaptive behaviors.

28. Nutrition Coaching
    Description: Guidance on anti-inflammatory diets.
    Purpose: Support overall health and recovery.
    Mechanism: Emphasizes foods rich in antioxidants and omega-3 fatty acids.

29. Peer Support Groups
    Description: Regular meetings with other ependymoma patients.
    Purpose: Share experiences and coping strategies.
    Mechanism: Social support buffers stress and fosters hope.

30. Fatigue Management Education
    Description: Training in pacing, energy conservation, and sleep hygiene.
    Purpose: Combat treatment-related fatigue.
    Mechanism: Balances activity with rest to optimize daily functioning.

---

Pharmacological Agents

Below are key drugs used in management of ependymoma-related symptoms or adjunct treatments. Each is described with class, typical dosage, timing, and side effects.

1. Dexamethasone (Corticosteroid)

   • Dosage & Timing: 4–10 mg IV/PO daily, taper as tolerated.

   • Purpose: Reduce peritumoral swelling and intracranial pressure.

   • Side Effects: Elevated blood sugar, insomnia, mood swings, osteoporosis.

2. Temozolomide (Alkylating Agent)

   • Dosage & Timing: 150–200 mg/m² PO once daily for 5 days every 28 days.

   • Purpose: Chemotherapy for recurrent or high-grade tumors.

   • Side Effects: Nausea, myelosuppression, fatigue, risk of infection.

3. Carboplatin (Platinum Compound)

   • Dosage & Timing: AUC 5–6 IV every 4 weeks.

   • Purpose: Alternative chemo in pediatric cases.

   • Side Effects: Neutropenia, thrombocytopenia, nephrotoxicity.

4. Etoposide (Topoisomerase II Inhibitor)

   • Dosage & Timing: 100 mg/m² IV daily × 3 days every 21 days.

   • Purpose: Often combined with carboplatin for relapse.

   • Side Effects: Alopecia, mucositis, bone marrow suppression.

5. Bevacizumab (VEGF Inhibitor)

   • Dosage & Timing: 10 mg/kg IV every 2 weeks.

   • Purpose: Reduce tumor vascularity and edema.

   • Side Effects: Hypertension, proteinuria, delayed wound healing.

6. Proton Pump Inhibitors (e.g., Omeprazole)

   • Dosage & Timing: 20–40 mg PO daily.

   • Purpose: Protect gastric mucosa during steroid use.

   • Side Effects: Headache, diarrhea, long-term osteoporosis risk.

7. Levetiracetam (Antiepileptic)

   • Dosage & Timing: 500–1500 mg PO BID.

   • Purpose: Prevent or treat seizures.

   • Side Effects: Irritability, fatigue, dizziness.

8. Phenytoin (Antiepileptic)

   • Dosage & Timing: 300–400 mg PO daily in divided doses.

   • Purpose: Long-term seizure prophylaxis.

   • Side Effects: Gum hyperplasia, ataxia, rash.

9. Ondansetron (5-HT3 Antagonist)

   • Dosage & Timing: 4–8 mg IV/PO every 8 hours PRN.

   • Purpose: Control chemo-induced nausea.

   • Side Effects: Headache, constipation.

10. Prochlorperazine (Antiemetic)

    • Dosage & Timing: 5–10 mg PO/IV every 6 hours PRN.

    • Purpose: Additional nausea control.

    • Side Effects: Sedation, extrapyramidal symptoms.

11. Mannitol (Osmotic Diuretic)

    • Dosage & Timing: 0.25–1 g/kg IV over 30–60 minutes PRN.

    • Purpose: Rapid reduction of intracranial pressure.

    • Side Effects: Electrolyte imbalance, dehydration.

12. Fluoxetine (SSRI Antidepressant)

    • Dosage & Timing: 20 mg PO daily.

    • Purpose: Manage depression and fatigue.

    • Side Effects: Nausea, insomnia, sexual dysfunction.

13. Gabapentin (Neuropathic Pain)

    • Dosage & Timing: 300 mg PO TID, titrate to 900–3600 mg/day.

    • Purpose: Relieve nerve pain from tumor compression.

    • Side Effects: Drowsiness, dizziness, peripheral edema.

14. Duloxetine (SNRI Antidepressant)

    • Dosage & Timing: 30 mg PO daily for pain and mood.

    • Purpose: Treat neuropathic pain and anxiety.

    • Side Effects: Dry mouth, constipation, insomnia.

15. Acetaminophen (Analgesic)

    • Dosage & Timing: 500–1000 mg PO every 6 hours PRN (max 3 g/day).

    • Purpose: Mild to moderate pain relief.

    • Side Effects: Liver toxicity at high doses.

16. Ibuprofen (NSAID)

    • Dosage & Timing: 200–400 mg PO every 6–8 hours PRN.

    • Purpose: Reduce inflammation and mild pain.

    • Side Effects: GI upset, renal impairment.

17. Cyclophosphamide (Alkylating Agent)

    • Dosage & Timing: 750 mg/m² IV every 21 days.

    • Purpose: High-dose regimen for refractory cases.

    • Side Effects: Hemorrhagic cystitis, myelosuppression.

18. Ifosfamide (Alkylating Agent)

    • Dosage & Timing: 1.5 g/m² IV daily × 5 days every 21 days.

    • Purpose: Alternative in relapse protocols.

    • Side Effects: Neurotoxicity, nephrotoxicity.

19. Vincristine (Vinca Alkaloid)

    • Dosage & Timing: 1.5 mg/m² IV weekly.

    • Purpose: Paired with other agents in combination chemo.

    • Side Effects: Peripheral neuropathy, constipation.

20. Methotrexate (Antimetabolite)

    • Dosage & Timing: 8 g/m² IV every 2 weeks with leucovorin rescue.

    • Purpose: High-dose chemo for central nervous system penetration.

    • Side Effects: Mucositis, nephrotoxicity, myelosuppression.

---

Dietary Molecular Supplements

These supplements may support overall health and adjunctive care for ependymoma patients.

1. Curcumin (Turmeric Extract)

   • Dosage: 500–2000 mg/day with black pepper extract for absorption.

   • Function: Anti-inflammatory and antioxidant.

   • Mechanism: Inhibits NF-κB and COX-2 pathways.

2. Omega-3 Fatty Acids (EPA/DHA)

   • Dosage: 1–3 g/day.

   • Function: Anti-inflammatory support.

   • Mechanism: Modulates eicosanoid production and reduces cytokines.

3. Resveratrol

   • Dosage: 150–500 mg/day.

   • Function: Antioxidant and potential anti-tumor effects.

   • Mechanism: Activates SIRT1 and induces apoptosis in malignant cells.

4. Green Tea Extract (EGCG)

   • Dosage: 250–500 mg/day standardized to ≥50% EGCG.

   • Function: Antioxidant and anti-angiogenic.

   • Mechanism: Inhibits VEGF and MMP enzymes.

5. Vitamin D3 (Cholecalciferol)

   • Dosage: 2000–5000 IU/day.

   • Function: Immune modulation and bone health.

   • Mechanism: Binds VDR to regulate cell proliferation.

6. Quercetin

   • Dosage: 500 mg twice daily.

   • Function: Anti-inflammatory and antihistamine.

   • Mechanism: Inhibits PI3K/Akt and MAPK pathways.

7. N-Acetylcysteine (NAC)

   • Dosage: 600–1200 mg/day.

   • Function: Antioxidant precursor to glutathione.

   • Mechanism: Scavenges free radicals and supports detoxification.

8. Sulforaphane (Broccoli Sprout Extract)

   • Dosage: 30–60 mg/day standardized.

   • Function: Induces phase II detox enzymes.

   • Mechanism: Activates Nrf2 pathway.

9. Melatonin

   • Dosage: 3–10 mg at bedtime.

   • Function: Sleep regulation and antioxidant.

   • Mechanism: Scavenges ROS and modulates circadian rhythm.

10. Probiotic Blend (Lactobacillus & Bifidobacterium)

    • Dosage: ≥10 billion CFU/day.

    • Function: Support gut health and immunity.

    • Mechanism: Balances microbiome and reduces systemic inflammation.

---

Advanced Drug Therapies

These specialized agents target bone health, regeneration, and lubricant support—often used in supportive care.

1. Zoledronic Acid (Bisphosphonate)

   • Dosage: 4 mg IV once yearly.

   • Function: Prevent bone metastasis–related complications.

   • Mechanism: Inhibits osteoclast-mediated bone resorption.

2. Alendronate (Bisphosphonate)

   • Dosage: 70 mg PO weekly.

   • Function: Strengthen bone and reduce fracture risk.

   • Mechanism: Binds hydroxyapatite and blocks osteoclast activity.

3. Recombinant Human Parathyroid Hormone (Teriparatide)

   • Dosage: 20 µg SC daily.

   • Function: Stimulate new bone formation.

   • Mechanism: Activates osteoblasts via PTH receptor.

4. Hyaluronic Acid Injections (Viscosupplementation)

   • Dosage: 20 mg intra-articular weekly × 3–5 weeks.

   • Function: Lubricate joints for pain relief.

   • Mechanism: Restores synovial fluid viscosity.

5. Platelet-Rich Plasma (PRP) (Regenerative)

   • Dosage: 3–5 mL per injection monthly.

   • Function: Promote tissue healing around surgical sites.

   • Mechanism: Delivers growth factors (PDGF, TGF-β) to injury site.

6. Mesenchymal Stem Cell Therapy

   • Dosage: 1–5 million cells/kg IV or direct injection.

   • Function: Support neural repair and modulate inflammation.

   • Mechanism: Differentiate into supportive cells and secrete trophic factors.

7. Bone Morphogenetic Protein-2 (BMP-2)

   • Dosage: 1.5 mg in collagen sponge at fusion site.

   • Function: Enhance spinal fusion after tumor resection.

   • Mechanism: Stimulates mesenchymal cell differentiation into osteoblasts.

8. Epidural Hyaluronidase

   • Dosage: 1500 units with local anesthetic.

   • Function: Improve diffusion of pain medication.

   • Mechanism: Breaks down hyaluronic acid in extracellular matrix.

9. Autologous Chondrocyte Implantation

   • Dosage: Single surgical graft.

   • Function: Repair cartilage defects after spinal surgery.

   • Mechanism: Implanted cells produce new cartilage matrix.

10. Autologous Stem Cell–Seeded Scaffolds

    • Dosage: Surgical implantation of cell-laden biomaterial.

    • Function: Regenerate bone and soft tissue defects post-resection.

    • Mechanism: Scaffold delivers cells and growth factors for tissue ingrowth.

---

Surgical Procedures

Surgical removal remains the cornerstone of ependymoma treatment.

1. Gross Total Resection (GTR)
   Procedure: Complete tumor removal under a microscope.
   Benefits: Best chance for cure and longer survival.

2. Subtotal Resection
   Procedure: Partial removal when full resection risks critical structures.
   Benefits: Reduces mass effect while preserving function.

3. Ventriculoperitoneal Shunt Placement
   Procedure: Catheter from ventricle to peritoneum to drain CSF.
   Benefits: Relieves hydrocephalus and intracranial pressure.

4. Endoscopic Third Ventriculostomy
   Procedure: Creates an opening in the floor of the third ventricle for CSF flow.
   Benefits: Less invasive hydrocephalus management.

5. Spinal Laminectomy with Tumor Resection
   Procedure: Removal of posterior vertebral bone to access spinal tumor.
   Benefits: Decompresses spinal cord and nerves.

6. Intraoperative MRI–Guided Resection
   Procedure: Real-time imaging during surgery to ensure maximal removal.
   Benefits: Improves completeness of resection and spares normal tissue.

7. Awake Craniotomy
   Procedure: Patient remains awake for language and motor testing.
   Benefits: Protects eloquent brain areas during removal.

8. Laser Interstitial Thermal Therapy (LITT)
   Procedure: MRI-guided laser probe ablates tumor.
   Benefits: Minimally invasive, suitable for deep-seated lesions.

9. Skull Base Approaches
   Procedure: Specialized corridors (e.g., subtemporal) for tumors at skull base ventricles.
   Benefits: Direct access with minimal brain retraction.

10. Spinal Fusion with Instrumentation
    Procedure: Hardware placement to stabilize spine after tumor removal.
    Benefits: Prevents deformity and maintains alignment.

---

Preventive Measures

Preventing ependymoma itself isn’t currently possible, but these steps support overall brain health and early detection:

1. Regular Neurological Check-ups for high-risk individuals (e.g., genetic syndromes)

2. Protective Headgear when engaging in contact sports

3. Avoidance of Head-and-Neck Radiation unless absolutely necessary

4. Healthy Diet rich in antioxidants and anti-inflammatory foods

5. Smoking Cessation to reduce systemic inflammation

6. Moderate Alcohol Intake to minimize neurotoxic effects

7. Blood Pressure Control to support cerebrovascular health

8. Occupational Safety reducing exposure to neurotoxins

9. Prompt Evaluation of Persistent Headaches for early imaging

10. Stress Management through mind-body practices

---

When to See a Doctor

Seek medical attention promptly if you experience:

• New or worsening headaches, especially worse in the morning or with coughing

• Nausea or vomiting without clear cause

• Changes in vision, balance, or coordination

• Weakness or numbness in arms or legs

• Unexplained changes in bladder or bowel control

• Seizures or sudden confusion

• Difficulty speaking or understanding language

• Personality or cognitive changes

• Persistent back pain unrelieved by rest

• Any neurological symptom that is new, severe, or progressive

---

“What to Do” and “What to Avoid”

What to Do:

1. Follow prescribed treatment plans exactly.

2. Keep regular follow-up imaging appointments.

3. Maintain a balanced diet and good hydration.

4. Engage in gentle exercise as tolerated.

5. Practice stress-reduction techniques daily.

6. Report any new symptoms immediately.

7. Seek support from counselors or support groups.

8. Adhere to seizure-precaution guidelines if applicable.

9. Take medications on schedule, including steroids and antiemetics.

10. Keep a symptom diary to share with your care team.

What to Avoid:

1. Skipping medications or follow-up visits.

2. High-impact sports that risk head or spine injury.

3. Excessive alcohol or recreational drug use.

4. Self-medicating without consulting your doctor.

5. Unverified alternative therapies that may interfere with treatment.

6. Prolonged fasting without medical supervision.

7. Ignoring mild symptoms until they worsen.

8. Overexertion during the acute recovery phase.

9. Driving if you experience seizures or severe imbalance.

10. Sudden discontinuation of corticosteroids (always taper).

---

Frequently Asked Questions

1. What causes ependymoma?
   Ependymomas arise from genetic changes in ependymal cells. While most occur sporadically, a small percentage link to inherited syndromes such as neurofibromatosis type 2.

2. Is ependymoma cancer?
   Yes. Ependymoma is a primary central nervous system tumor. Grades II–III are considered malignant due to invasive growth and recurrence risk.

3. How is ependymoma diagnosed?
   Diagnosis involves MRI to locate the lesion and a surgical biopsy to confirm cell type and grade under a microscope.

4. What are treatment options?
   Treatment typically combines surgical resection with radiation therapy. Chemotherapy may be used for high-grade or recurrent tumors.

5. Can ependymoma be cured?
   Complete removal (gross total resection) followed by radiation offers the best chance of long-term control, especially in low-grade tumors.

6. What is the survival rate?
   Five-year survival varies by age and grade, ranging from about 50 % in high-grade adult cases to 80 % in children with low-grade tumors.

7. What are common side effects of treatment?
   Surgery can cause neurological deficits; radiation may lead to fatigue, hair loss, and cognitive changes; chemo often causes nausea and low blood counts.

8. How often should I have follow-up imaging?
   Typically, MRIs are done every 3–6 months for the first two years, then annually if stable.

9. Can I exercise after treatment?
   Yes—gentle activities like walking, yoga, and swimming, once cleared by your care team, help recovery and well-being.

10. Are seizures common?
    Up to 20–30 % of patients experience seizures, particularly those with cortical or spinal involvement. Antiepileptic medications help control them.

11. What diet supports recovery?
    A balanced diet rich in fruits, vegetables, lean protein, and healthy fats supports healing and reduces inflammation.

12. Is there a genetic test?
    Molecular profiling of tumor tissue can guide prognosis and targeted therapies but is not routinely done in all centers.

13. Can ependymoma recur?
    Yes. Recurrence occurs in up to 50 % of high-grade cases. Lifelong monitoring is recommended.

14. Are there clinical trials?
    Ongoing trials explore targeted therapies, immunotherapies, and novel drug combinations. Ask your oncologist about eligibility.

15. How can I cope emotionally?
    Counseling, support groups, and mind-body practices like mindfulness can improve quality of life and reduce anxiety

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 01, 2025.